MACRA Program Modifications and Determining Reimbursement Exposure


MACRA Program Modifications and Determining Reimbursement Exposure

Wednesday, May 9th, 2018,  11:00 AM  (EST)  






Raj Lakhanpal, MD, FRCS, FACEP
Chief Executive Officer, SpectraMedix
Member, HIMSS BI and Clinical Intelligence Committee
Member, Governance Board, MITA (Medicaid Information Technology Architecture)
Marc Bryant 
Director of Sales, SpectraMedix

CMS recently reinforced that MACRA programs are here to stay, and we are now well into Q2 of the 2018 CMS performance year. Whether hospitals and their eligible clinicians are ready for it or not, MACRA will impact operations and bottom line.

Join our experts at SpectraMedix, selected by NJHA Healthcare Business Solutions as its MACRA solution partner, in helping NJHA members navigate:
•Key 2018 MACRA components and challenges
•Modifications to MACRA from the recent passing of the Bipartisan Budget Act of 2018
•MIPS and APM reporting for hospital-based eligible clinicians
•How to determine MIPS Medicare reimbursement financial exposure
•Reputational risk resulting from publicly-released scores
•How the SpectraMedix eMeasures360™ Platform enables providers to successfully implement MACRA

For more information about our quality program and improvement offerings, Contact Marc Bryant:

Request a Demo
WP-Backgrounds Lite by InoPlugs Web Design and Juwelier Schönmann 1010 Wien